Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
SIBN SI-BONE Inc
- Stocks
- Healthcare
- NASDAQ: SIBN
Price (delayed)
$19.79
Market cap
$843.34M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.64
Enterprise value
$839.31M
SI-BONE is a medical device company that pioneered minimally invasive surgery of the SI joint with the iFuse Implant System. Studies have shown that the SI joint can be a
Highlights
The EPS rose by 41% YoY and by 15% QoQ
SI-BONE's net income has increased by 38% YoY and by 14% QoQ
SI-BONE's quick ratio has decreased by 17% YoY but it has increased by 9% QoQ
Key stats
What are the main financial stats of SIBN
Market
Valuations
Earnings
Shares outstanding
42.61M
Market cap
$843.34M
Enterprise value
$839.31M
Price to earnings (P/E)
N/A
Price to book (P/B)
5.02
Price to sales (P/S)
4.74
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.75
Revenue
$176.6M
Gross profit
$139.95M
Operating income
-$30.69M
Net income
-$26.55M
EBIT
-$23.33M
EBITDA
-$18.76M
Free cash flow
-$20.25M
Per share
Balance sheet
Liquidity
EPS
-$0.64
EPS diluted
-$0.64
Free cash flow per share
-$0.48
Book value per share
$3.94
Revenue per share
$4.17
TBVPS
$5.37
Total assets
$227.28M
Total liabilities
$60.02M
Debt
$37.15M
Equity
$167.26M
Working capital
$180.25M
Debt to equity
0.22
Current ratio
8.53
Quick ratio
7.14
Net debt/EBITDA
0.21
Margins
Efficiency
Dividend
EBITDA margin
-10.6%
Gross margin
79.2%
Net margin
-15%
Operating margin
-17.4%
Return on assets
-11.7%
Return on equity
-16%
Return on invested capital
-11.2%
Return on capital employed
-11.5%
Return on sales
-13.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SIBN stock price
How has the SI-BONE stock price performed over time
Intraday
4.82%
1 week
7.03%
1 month
48.46%
1 year
30.8%
YTD
41.16%
QTD
41.05%
Financial performance
How have SI-BONE's revenue and profit performed over time
Revenue
$176.6M
Gross profit
$139.95M
Operating income
-$30.69M
Net income
-$26.55M
Gross margin
79.2%
Net margin
-15%
SI-BONE's net margin has increased by 50% YoY and by 19% from the previous quarter
The company's operating margin rose by 47% YoY and by 18% QoQ
SI-BONE's net income has increased by 38% YoY and by 14% QoQ
The operating income is up by 36% year-on-year and by 13% since the previous quarter
Price vs fundamentals
How does SIBN's price correlate with its fundamentals
Growth
What is SI-BONE's growth rate over time
Valuation
What is SI-BONE stock price valuation
P/E
N/A
P/B
5.02
P/S
4.74
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.75
The EPS rose by 41% YoY and by 15% QoQ
SIBN's P/B is 43% above its last 4 quarters average of 3.5
The P/S is 35% more than the last 4 quarters average of 3.5 but 31% less than the 5-year quarterly average of 6.9
The company's revenue rose by 23% YoY and by 6% QoQ
Efficiency
How efficient is SI-BONE business performance
The ROS has soared by 52% YoY and by 20% QoQ
The ROIC has grown by 46% YoY and by 15% from the previous quarter
SI-BONE's ROA has increased by 38% YoY and by 15% from the previous quarter
The ROE has grown by 36% YoY and by 14% from the previous quarter
Dividends
What is SIBN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SIBN.
Financial health
How did SI-BONE financials performed over time
SI-BONE's quick ratio has decreased by 17% YoY but it has increased by 9% QoQ
The current ratio has declined by 13% year-on-year but it has grown by 11% since the previous quarter
SI-BONE's debt is 78% less than its equity
SI-BONE's debt has decreased by 4.1% YoY
The debt to equity has declined by 4.3% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.